Skip to main content

Table 3 Analysis of factors associated with placental parasite density among delivering women

From: Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania

Variable

Parasite density

Crude OR

P-value

Adjusted OR

P-value

 

N

No. of PD >100/μl, (%)

(95% CI)

 

(95% CI)

 

Maternal age

     

<20 years

42

22 (52.38)

2.04 (1.00, 4.16)

0.049

1.98 (0.76, 5.17)

0.162

≥20 years

120

42 (35.00)

Reference

 

Reference

 

Health facility

     

Geita hospital

93

23 (24.73)

Reference

 

Reference

 

Katoro HC

69

41 (59.42)

4.46 (2.27, 8.73)

<0.001

5.32 (2.45, 11.57)

<0.001

Gravidity

     

Paucigravidae

94

43 (45.74)

1.89 (0.98, 3.63)

0.058

2.05 (0.85, 4.93)

0.110

Multigravidae

68

21 (30.88)

Reference

 

Reference

 

Level of education

     

None/Primary

140

61 (43.57)

4.89 (1.38, 17.29)

0.014

3.18 (0.80, 12.55)

0.099

Secondary/Higher

22

3 (13.64)

Reference

 

Reference

 

Occupation

     

Peasant/livestock

143

61 (42.66)

3.97 (1.11, 14.23)

0.034

2.16 (0.53, 8.82)

0.285

Employed/Business

19

3 (15.79)

Reference

 

Reference

 

Bed net use

      

No

6

5 (88.33)

8.33 (0.95, 73.13)

0.056

12.88 (1.27, 130.15)

0.030

Yes

152

57 (37.50)

Reference

 

Reference

 

SP receipt

      

<3 doses

158

64 (40.51)

-

-

-

-

≥3 doses

4

0 (0.00)

    
  1. HC = health centre; OR = odds ratio, PD = parasite density, 95% CI = 95% confidence interval, SP = sulphadoxine-pyrimethamine; Significant p-values are presented in bold.